L'Oreal/Nestle venture sweetens Q-med bid

STOCKHOLM Thu Feb 10, 2011 2:40am EST

Related Topics

STOCKHOLM (Reuters) - The L'Oreal (OREP.PA) and Nestle (NESN.VX) joint venture Galderma said on Thursday it was raising its bid for Swedish beauty treatments firm Q-Med QMED.ST by about 5 percent.

Galderma raised its bid to 79 crowns per share, valuing the company at $1.16 billion. Earlier this week, Galderma said its 75 crown per share bid had fallen well short of a target for 90 acceptances.

Galderma said owners holding just under 78 percent of shares had agreed to accept the raised offer.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.